A similar dose-dependent competitive and non-competitive inhibition of DNMT by reduction of the cellular availability of SAM was found with 20–50 μmol/L genistein in oesophageal squamous cell carcinoma KYSE-150 cells and the prostate cancer cells lines LNCaP and PC-3 [129]. Here, DNMT1 is linked to prostate carcinoma.